Understanding Real-Life Response to Lurbinectedin as Second Line Therapy in Patients with Extensive Stage Small-Cell Lung Cancer

被引：0
|
作者：
Curt, K. [1 ]
Rice, J. [1 ]
Qin, A. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Lurbinectedin; Real-life efficacy; Extensive Stage Small Cell Lung Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP13.07-01
引用
收藏
页码：S705 / S706
页数：2
相关论文
共 50 条
  • [21] Prophylactic Cranial Irradiation in Patients with small-cell Lung Cancer in the Extensive Disease Stage
    Ziegler, D.
    Ziegler, S.
    Droege, L.
    Leu, M.
    Donath, S.
    Guhlich, M.
    Schirmer, M.
    Rieken, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S149 - S149
  • [22] LURBINECTEDIN IS SAFE AND ACTIVE IN RELAPSED SMALL-CELL LUNG CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (06) : 757 - 757
  • [23] Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
    Eckardt, John R.
    Bentsion, Dimitri L.
    Lipatov, Oleg N.
    Polyakov, Igor S.
    MacKintosh, Frederick R.
    Karlin, David A.
    Baker, Gizelle S.
    Breitz, Hazel B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2046 - 2051
  • [24] A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)
    Oronsky, Bryan
    Abrouk, Nacer
    Caroen, Scott
    Lybeck, Michelle
    Guo, Xiaoning
    Wang, Xiaohui
    Yu, Zhongwen
    Reid, Tony
    JOURNAL OF CANCER, 2022, 13 (09): : 2945 - 2953
  • [25] EMERGE 402: Preliminary Real-world Characteristics and Safety of Lurbinectedin in Patients With Small-cell Lung Cancer
    Bushunow, P.
    Dakhil, S.
    Lammers, P.
    Naveh, N.
    Boccuti, A.
    Hanvesakul, R.
    Li, W.
    Migas, J.
    Slater, D.
    Badin, F.
    Halmos, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S145 - S146
  • [26] Extensive-stage small-cell lung cancer: Evolution of systemic therapy and future directions
    Allen, Jeffrey
    Jahanzeb, Mohammad
    CLINICAL LUNG CANCER, 2008, 9 (05) : 262 - 270
  • [27] The Impact of Response on Survival in Extensive-Stage Small-Cell Lung Cancer in the CASPIAN Study
    Johal, S.
    Fischer, C.
    Cawston, H.
    Jiang, H.
    Brannman, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S542 - S543
  • [28] Second-line treatment of small-cell lung cancer
    MacCallum C.
    Gillenwater H.H.
    Current Oncology Reports, 2006, 8 (4) : 258 - 264
  • [29] First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
    Horn, L.
    Mansfield, A. S.
    Szczesna, A.
    Havel, L.
    Krzakowski, M.
    Hochmair, M. J.
    Huemer, F.
    Losonczy, G.
    Johnson, M. L.
    Nishio, M.
    Reck, M.
    Mok, T.
    Lam, S.
    Shames, D. S.
    Liu, J.
    Ding, B.
    Lopez-Chavez, A.
    Kabbinavar, F.
    Lin, W.
    Sandler, A.
    Liu, S. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23): : 2220 - 2229
  • [30] Real-world treatment patterns and survival in extensive stage small-cell lung cancer in Japan
    Horinouchi, Hidehito
    Chang, Chia-Hsien Suzu
    Shaw, Jaime
    Archangelidi, Olga
    Balasubramanian, Akhila
    Pundole, Xerxes
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
12345